申请人:Sanofi
公开号:US04332805A1
公开(公告)日:1982-06-01
Decahydroquinolinol derivatives corresponding to the general formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, in which R.sup.1 represents hydrogen, a methyl, ethyl, n-propyl, n-butyl or phenyl radical or a phenyl radical having one substituent or two identical or different substituents selected from chlorine, bromine atoms and a methyl group. Ar represents a phenyl or naphthyl radical or a phenyl radical having one substituent or two identical or different substituents selected from fluorine, chlorine and bromine atoms and methyl, methoxy, acetyl and cyano groups, X represents oxygen or sulfur, n represents 2 or 3. They are useful as antiarrhthmic and local anaesthetic agents.
脱氢氢化喹啉醇衍生物对应于以下一般公式:##STR1##及其在药学上可接受的酸盐,其中R.sup.1代表氢、甲基、乙基、正丙基、正丁基或苯基或具有一个取代基或两个相同或不同取代基,所选自氯、溴原子和甲基的苯基。Ar代表苯基或萘基或具有一个取代基或两个相同或不同取代基,所选自氟、氯和溴原子和甲基、甲氧基、乙酰基和氰基的苯基。X代表氧或硫,n代表2或3。它们可用作抗心律失常和局部麻醉剂。